Acute liver failure

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 9, 1999, Pages 943-947

  Smithson, John E ^a   Neuberger, James M ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; CLAVULANIC ACID; FLUCLOXACILLIN; HALOTHANE; HISTAMINE H2 RECEPTOR ANTAGONIST; ISONIAZID PLUS RIFAMPICIN; MANNITOL; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

ALCOHOLISM; BACTERIAL INFECTION; BRAIN EDEMA; DISEASE CLASSIFICATION; DRUG INTOXICATION; DRUG TOXICITY; EDITORIAL; HEPATITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; THROMBOCYTOPENIA; VIRUS HEPATITIS; WILSON DISEASE;

EID: 0032709454     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199909000-00001     Document Type: Editorial

References (39)

1. Trey C, Davidson CS. The management of fulminant hepatic failure. In: Progress in Liver Failure. Popper H, Schaffner F (editors). New York: Grune and Stratton, 1970. pp. 282-298.
2. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342:273-275.
3. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure. Semin Liver Disease 1986; 6:97-106.
4. Takahashi Y, Shimizu M. Aetiology and prognosis of fulminant vital hepatitis in Japan: a multicentre study. J Gastroenterol Hepatol 1991; 6:159-164.
5. Bernuau J, Benhamou JP. Classifying acute liver failure. Lancet 1993; 342:252-253.
6. Williams R. Classification and clinical syndromes of acute liver failure. In: Acute Liver Failure. Lee WM, Williams R (editors). Cambridge: Cambridge University Press. 1997. pp. 1-9.
7. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley K, et al. Etiology and prognosis for 295 patients with acute liver failure in the US [Abstract]. Gastroenterology 1997; 122:A1376.
8. Zhuang H, Cao X-Y, Liu C-B, Wang G-M. Enterically transmitted non-A, non-B hepatitis in China. In: Viral Hepatitis C, D and E. Shikata T, Purcell RH, Uchida T (editors). Amsterdam: Elsevier Science Publishers BV, 1991. pp. 277-285.
9. Nanda SK, Yalcinkaya K, Panigrahi AK, Acharya SK, Jameel S, Panda SK. Etiological role of hepatitis E in sporadic fulminant hepatitis. J Med Virol 1994; 42:133-137.
10. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bismuth H, Brechot C. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993; 104:549-555.
11. Chu C-M, Sheen J-S. Liaw Y-F. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994; 107:189-195.
12. Papaevangelou G, Tassoupolos N, Roumelioutou-Karayannis A, Richardson C. Etiology of fulminant viral hepatitis in Greece. Hepatology 1984; 4:369-372.
13. McNeil M, Hoy JF, Richards MJ, Lehmann NI, Dimitrikakis M, Gust ID, Lucas CR. Aetiology of fatal viral hepatitis in Melbourne. A retrospective study. Med J Aust 1984; 141:637-640.
14. Hughes RD, Wendon J, Gimson AES. Acute liver failure. Gut 1991; (suppl):S86-S91.
15. van Thiel DH. When should a decision to proceed with transplantation actually be made in cases of fulminant or subfulminant hepatic failure: at admission to hospital or when a donor organ is made available? J Hepatol 1993; 17:1-2.
16. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Casewell M, Williams R. Fungal infection: a common unrecognized complication of acute liver failure. J Hepatol 1991; 12:1-9.
17. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson AES, Casewell M, Williams R. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990; 11:49-53.
18. MacDougall BRD, Bailey RJ, Williams R. H2-receptor antagonists in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Lancet 1977; 1:617-619.
19. Penn RG, Sanders WE, Sanders CC. Colonization of the oropharynx with Gram-negative bacilli: a major antecedent to nosocomial pneumonias. Am J Infect Control 1981; 9:25-34.
20. Triger DR, Slater DN, Goepel JR, Underwood JCE. Systemic candidiasis complicating acute hepatic failure in patients treated with cimetidine. Lancet 1981;ii:837-838.
21. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 1991; 324:1852-1858.
22. Wendon J, Harrison P, Keays R, Gimson A, Alexander G, Williams R. Effects of vasopressor agents and eprostenol on systemic hemodynamics and oxygen transport variables in patients with fulminant hepatic failure. Hepatology 1992; 12:1067-1071.
23. Canalese J, Gimson AES, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982; 23:625-629.
24. Forbes A, Alexander GJM. O'Grady JG, Keays R, Gullan R, Dawling S, Williams R. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989; 10:306-310.
25. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341:157-158.
26. Davies MH, Mutimer DJ, Lowes J, Elias E, Neuberger JM. Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet 1994; 343:1329-1330.
27. Lidofsky SD, Bass NM, Prager MC, Washington DE, Read AE, Wright TL, et al. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure. Hepatology 1992; 16:1-7.
28. Larsen FS, Knudsen GM, Hansen BA. Pathophysiological changes in cerebral circulation, oxidative metabolism and blood-brain barrier in patients with acute liver failure. J Hepatol 1997; 27:231-238.
29. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. BMJ 1979; ii:1097-1100.
30. Smilkstein MJ, Knapp HL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 1988; 319:1557-1562.
31. Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335:1572-1573.
32. Keays R, Harrison PM, Wendon J, Forbes A, Gove C, Alexander GJM, Williams R. Intravenous acetylcysteine in paracetamol-induced fulminant hepatic failure: a prospective controlled trial. BMJ 1991; 303:1026-1029.
33. Mutimer DJ, Ayres RCS, Neuberger JM, Davies MH, Holguin J, Buckels JAC, et al. Serious paracetamol poisoning and the results of liver transplantation. Gut 1994; 35:809-814.
34. Bismuth H, Samuel D, Castaing D, Adam R, Saliba F, Johan M, et al. Orthotopic liver transplantation in fulminant and sub-fulminant hepatitis. Ann Surg 1995; 222:109-119.
35. Bernal W, Wendon J, Rela M, Heaton N, Williams R. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998; 27:1050-1055.
36. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97:439-445.
37. Bernuau J, Samuel D, Durand RMS, Bourliere M, Adam R, Gugenheim J, et al. Criteria for emergency liver transplantation in patients with acute viral hepatitis and Factor V below 50% of normal: a prospective study [Abstract]. Hepatology 1991; 14:49A.
38. Gubernatis G, Pichlmayr R, Kemnitz J, Gratz K. Auxiliary partial orthotopic liver transplantation (APOLT) for fulminant hepatic failure. First Successful case report. World J Surg 1991; 15:660-666.
39. Jones AL, Hayes PC, Proudfoot AT, Vale JA, Prescott LF, Krenzelok EP. Should methionine be added to every paracetamol tablet? BMJ 1997; 315:301-304.